STOCK TITAN

T. Rowe Price holds 9.87M shares of Shattuck Labs (NASDAQ: STTK) amendment

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Shattuck Labs Inc. ownership filing reports that T. Rowe Price Investment Management, Inc. holds 9,865,558 shares of common stock, representing 13.8% of the class as shown for the period 03/31/2026. The filer states sole voting power for 9,831,415 shares and sole dispositive power for 9,865,558 shares. The filing is an amendment and is signed by a Vice President on 05/15/2026.

Positive

  • None.

Negative

  • None.

Insights

T. Rowe Price reports a sizable 13.8% stake in STTK as of 03/31/2026.

The filing shows 9,865,558 shares beneficially owned with sole voting power on 9,831,415 shares, indicating control over voting for most of the position. This is a passive ownership disclosure typical for large institutional holders.

Cash‑flow treatment or planned transactions are not disclosed here; subsequent amendments or Schedule 13D would show active changes if they occur.

The Schedule 13G/A is an amendment confirming reported beneficial ownership and voting/dispositive details.

The form lists the issuer CUSIP 82024L103 and identifies the filer as a Maryland entity. It includes explicit counts for voting and dispositive power, which matter for regulatory thresholds and reporting obligations.

Any change above reporting thresholds would require further amendment; monitor future filings for shifts in percent ownership or change in voting status.

Beneficial ownership 9,865,558 shares Amount beneficially owned as reported
Percent of class 13.8% Percent of class as reported for <date>03/31/2026</date>
Sole voting power 9,831,415 shares Sole power to vote or to direct the vote
Sole dispositive power 9,865,558 shares Sole power to dispose or direct disposition
CUSIP 82024L103 Issuer identifier for common stock
Reporting period 03/31/2026 Period shown near top of filing
Signature date 05/15/2026 Date the amendment was signed
Schedule 13G/A regulatory
"Amendment No. 1 ) SHATTUCK LABS INC COMMON STOCK"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficial ownership regulatory
"Item 4. | Ownership (a) | Amount beneficially owned: 9865558"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Sole dispositive power regulatory
"(iii) Sole power to dispose or to direct the disposition of: 9865558"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
CUSIP technical
"COMMON STOCK 82024L103 03/31/2026"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does T. Rowe Price hold in SHATTUCK LABS (STTK)?

T. Rowe Price reports beneficial ownership of 9,865,558 shares (13.8%) as of 03/31/2026. The filing shows sole dispositive power over 9,865,558 shares and sole voting power over 9,831,415 shares, per the amendment signed 05/15/2026.

Does the filing show voting power for the T. Rowe Price position in STTK?

Yes. The filer reports sole voting power on 9,831,415 shares and shared voting power of 0. These counts are disclosed in the amendment and correspond to the 03/31/2026 reporting period.

Is this Schedule 13G/A a signal of active control or passive ownership?

This Schedule 13G/A format typically indicates institutional/passive ownership rather than an acquisition for control. The filing lists voting and dispositive counts without describing plans to change control or sell, consistent with passive reporting practice.

What identifiers and dates appear on the T. Rowe Price amendment for STTK?

The filing lists CUSIP 82024L103, a reporting period of 03/31/2026, and a signature date of 05/15/2026. It is labeled as an amendment (Schedule 13G/A) for common stock.

Who signed the Schedule 13G/A on behalf of T. Rowe Price?

The amendment is signed by Ellen York, Vice President, with the signature date shown as 05/15/2026. The filing includes a statement disclaiming beneficial ownership by the investment manager.





82024L103

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:05/15/2026